Madrigal Pharmaceuticals
Conshohocken
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases. The company targets the treatment of both niche and prevalent indications, including diabetes, dyslipidemia, and cardiovascular disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $1.9B
- Funding stage: M&A
- Last round: Post-IPO Debt (Jul 2025)
- Ticker: nasdaq:MDGL
- Website: madrigalpharma.com
- Phone: +1 267 327 4445
Industries & Categories
Biopharma, Biotechnology, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/madrigal-pharmaceuticals-35408 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.